association of snps in interferon receptor genes in chronic hepatitis c with response to combined therapy of interferon and ribavirin.

نویسندگان

zohreh heidari digestive oncology research center digestive diseases research institute, tehran university of medical sciences, tehran, iran.

kiana shahzamani department of biology, faculty of sciences, lorestan university, khorram-abad, iran.

reza ghanbari digestive oncology research center digestive diseases research institute, tehran university of medical sciences, tehran, iran.

arash tahamsebifar cellular and molecular research center, golestan university of medical sciences, gorgan, iran.

چکیده

hepatitis c virus is one of the main reasons for chronic liver disease and hepatocellular carcinoma. combination therapy with interferon (peg-ifn-α) and ribavirin (rbv) clear the virus more likely than the others. different factors like virus and host characteristics influence on response to treatment. the most important viral factors include virus genotype and viral load; host factors like genetic, gender, race, age, weight and liver enzymes are also important. previous studies have shown that single nucleotide polymorphisms (snps) in ifnr genes can regulate and influence on treatment with ifn. the purpose of this study is to investigate the association between snps in ifn-α receptor (ifnar1 & ifnar2) genes among subjects affected with chronic hepatitis c, who have treated with ifn and rbv, and also relationship between hcv genotypes and response to combination antiviral therapy. peripheral blood mononuclear cells (pbmcs) were taken from whole blood of 61 patients affected with chronic hepatitis c who were treated with ifn and ribavirin. then, dna was extracted from pbmcs and quality of dna was assessed with nanodrop finally two snps [ex4-30g>c] and [ivs1-4640 g>a] of ifn receptor genes (ifnar1 and ifnar2) were measured by taqman real-time pcr in abi prism 7900 system. also to confirm the response rate to therapy, rna was extracted then rt pcr was performed and final product was studied with gel electrophoresis and uv spectroscopy. statistical analysis was performed using spss version 18.0 for windows. the analysis of results from taqman snp genotyping has been shown that two snps (ex4-30g>c and ivs1-4640 g>a) of ifnar1 and ifnar2 didn't show any relationship with response to combined therapy in subjects affected with chronic hepatitis c who have treated with peg-ifn-α and ribavirin. 61 patients complete the treatment period. 54 patients (%88/5) of them responded to treatment and 7 patients (%11/5) did not. research and data analysis have shown that there is no significant relationship between sex (p=0 /7) and age (p=0 /2). but there is a relationship between genotype-3a and response to combined therapy of ifn-α and rbv (0/02). studies have shown that gene polymorphisms in ivss1-22g location of ifnar1 gene had a relationship with ifn treatment response. but current study has shown that there is no significant relationship between two snps ex4-30g>c and ivs1-4640 g>a and response to ifn therapy. in continue we suggest that it would be better to use this technique to evaluate other snps in ifn genes.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

EFFICACY AND SAFETY OF COMBINATION THERAPY OF INTERFERON-ALPHA 2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C

Introduction: The aim of this study is to assess the therapeutic efficacy and safety of a particular brand of IFN alpha (PDferon B®) in combination with ribavirin (RlBA) on Iranian patients with chronic hepatitis C (CHC). The addition of RIBA to the standard treatment with interferon (IFN) alpha led to an improvement in sustained virologic response (SVR) from less than 20% with IFN monother...

متن کامل

Response to combination therapy of interferon alfa-2b plus ribavirin in Hispanics with chronic hepatitis C.

OBJECTIVE To evaluate the response rate of Hispanics with chronic hepatitis C to combination therapy of interferon alfa-2b plus ribavirin and to assess its adverse events. BACKGROUND Hepatitis C virus may lead to chronic infection and multiple complications. Response to combination therapy of interferon plus ribavirin has been studied in many populations. African Americans have been found to ...

متن کامل

A MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF HEBER ON (INTERFERON ALFA-2b) IN COMBINATION WITH RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C IN IRAN

 ABSTRACT Background: Combination therapy with interferon and ribavirin is the most effective treatment for chronic hepatitis C today. The aim of this study was to evaluate the efficacy and safety of thrice-weekly Heberon (interferon alfa-2b) in combination with ribavirin as first -line treatment of chronic hepatitis C. Methods: A total of97 treatment-naive patients received Heberon three milli...

متن کامل

PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C.

Pegylated interferon (PEG-IFN) alpha combined with ribavirin is the current standard treatment for hepatitis C, but around 50% of patients do not respond for reasons that are not fully understood. To explore the regulation of IFN-inducible protein kinase (PKR), we have measured PKR mRNA levels in peripheral blood mononuclear cells (PBMCs) and in liver biopsies from patients with chronic hepatit...

متن کامل

Response to standard interferon A2b and ribavirin combination therapy in chronic hepatitis C treatment naive patients.

BACKGROUND Treatment of Chronic Hepatitis C is now well established with conventional interferon or pegylated interferon in combination with ribavirin. Peginterferon Alfa and Ribavirin for 6 to 12 months is currently approved initial therapy, which is expensive. Response of our patients to standard Interferon-alpha-2b and ribavirin for 24 weeks have been studied. The objective of this study was...

متن کامل

Influence of Vitamin D Receptor Gene Polymorphisms on Response to Pegylated Interferon in Chronic Hepatitis B Egyptian Patients

Background: We explored the effect of vitamin D receptor gene (VDR) polymorphisms in response to PEG-IFN treatment in Egyptian chronic hepatitis B (CHB) patients. Methods: Two hundred hepatitis B virus (HBV) patients (42.3±10.7 years) on PEG-IFN α-2a (180 μg /kg for 48 weeks) and one hundred control subjects (37.3 ±12 years) were enrolled in the study. Vitamin D levels a...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
acta medica iranica

جلد ۵۲، شماره ۱۰، صفحات ۷۴۰-۷۴۷

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023